What Hedge Funds Think About ArQule, Inc. (ARQL)
In the 21st century investor’s toolkit, there are many metrics shareholders can use to monitor stocks. A duo of the most innovative are hedge fund and insider trading sentiment.
Durata Therapeutics Inc. (DRTX)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Aisling Capital Dennis Purcell | 0 | $0 | 0% | |
| 2. | PDT Partners Peter Muller | 0 | $0 | 0% | |
| 3. | OrbiMed Advisors Samuel Isaly | 0 | $0 | 0% | |
| 4. | 0 | $0 | 0% | ||
| 5. | 0 | $0 | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $13.72 | 3,000 | $41,160.00 | 11,000 | 2014-08-12 | Filing | |
| $15.23 | 3,000 | $45,690.00 | 45,636 | 2014-06-12 | Filing | |
| $15.57 | 15,000 | $233,505.00 | 15,000 | 2014-05-12 | Filing | |
| $8.25 | 500 | $4,125.00 | 1,500 | 2012-08-06 | Filing | |
| $10.95 | 1,000 | $10,950.00 | 1,000 | 2013-12-03 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $15.57 | 2,649 | $41,255.00 | 3,030,175 | 2014-03-21 | Filing | |
| $15.74 | 98,000 | $1,542,588.60 | 3,032,824 | 2014-03-20 | Filing |
Institutional Investors' Holdings
News See All
What's a Smart Cytokinetics, Inc. (CYTK) Investor To Do?
In the eyes of many of your peers, hedge funds are seen as useless, old investment tools of a forgotten age.
OncoGenex Pharmaceuticals Inc (OGXI): Are Hedge Funds Right About This Stock?
To the average investor, there are many gauges shareholders can use to monitor stocks. Two of the most underrated are hedge fund and insider trading movement.
Cytokinetics, Inc. (CYTK): Hedge Funds Are Bullish and Insiders Are Bearish, What Should You Do?
Cytokinetics, Inc. (NASDAQ:CYTK) was in 8 hedge funds' portfolio at the end of March. CYTK shareholders have witnessed an increase in support from the world's most elite money managers of late.
Hedge Funds Are Crazy About Cytokinetics, Inc. (CYTK)
In today’s marketplace, there are tons of indicators investors can use to analyze publicly traded companies. Two of the most under-the-radar are hedge fund and insider trading movement.
Hedge Funds Are Dumping Cytori Therapeutics Inc. (USA) (CYTX)
In the eyes of most stock holders, hedge funds are perceived as underperforming, old financial tools of the past.
Do Hedge Funds and Insiders Love Durata Therapeutics Inc (DRTX)?
Durata Therapeutics Inc (NASDAQ:DRTX) was in 5 hedge funds' portfolio at the end of December. DRTX investors should be aware of a decrease in enthusiasm from smart money of late.
Hedge Funds Are Betting On Cytori Therapeutics Inc. (USA) (CYTX)
If you'd ask most stock holders, hedge funds are perceived as unimportant, outdated financial vehicles of the past.
Enzon Pharmaceuticals, Inc. (ENZN): Are Hedge Funds Right About This Stock?
If you'd ask most traders, hedge funds are seen as unimportant, old financial tools of yesteryear.
Billionaire Hedge Funds
